Patents by Inventor Yanxin ZHENG

Yanxin ZHENG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Angiotensin II receptor antagonist metabolite and NEP inhibitor composite and preparation method thereof
    Patent number: 11026925
    Abstract: Provided are a supramolecular composite comprising an angiotensin II receptor (AT1) blocking compound, a neutral endopeptidase inhibitor (NEPi), and a pharmaceutically acceptable cation. The invention further provides a method for preparing the composite and an application of the composite for preparing a pharmaceutical product for treating heart failure.
    Type: Grant
    Filed: January 19, 2017
    Date of Patent: June 8, 2021
    Assignee: SHENZHEN SALUBRIS PHARMACEUTICALS CO. LTD.
    Inventors: Jie Yan, Wenjie Xu, Jianqiong Zhi, Song Li, Yang Wang, Yanxin Zheng
  • ANGIOTENSIN II RECEPTOR ANTAGONIST METABOLITE AND NEP INHIBITOR COMPOSITE AND PREPARATION METHOD THEREOF
    Publication number: 20200061025
    Abstract: Provided are a supramolecular composite comprising an angiotensin II receptor (AT1) blocking compound, a neutral endopeptidase inhibitor (NEPi), and a pharmaceutically acceptable cation. The invention further provides a method for preparing the composite and an application of the composite for preparing a pharmaceutical product for treating heart failure.
    Type: Application
    Filed: January 19, 2017
    Publication date: February 27, 2020
    Inventors: Jie YAN, Wenjie XU, Jianqiong ZHI, Song LI, Yang WANG, Yanxin ZHENG